DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fontolizumab
Fontolizumab
Curriculum Vitae: Daniel J
Fontolizumab, a Humanised Anti-Interferon C Antibody
New Biological Therapies: Introduction to the Basis of the Risk of Infection
Tanibirumab (CUI C3490677) Add to Cart
Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
(INN) for Biological and Biotechnological Substances
246992764-Oa
Insights Into Gene Modulation by Therapeutic TNF and Ifnc Antibodies
Clinical Study Protocol
United States Patent (10 ) Patent No.: US 10,471,211 B2 Rusch Et Al
INN Working Document 05.179 Update 2011
Standards, Perspektiven Und Grenzen Der Konservativen Therapie
Stembook 2018.Pdf
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
Recent Biotherapies and Infections
Top View
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Dissecting the Heterogeneity in T-Cell Mediated Inflammation In
New Targets for Mucosal Healing and Therapy in Inflammatory Bowel Diseases
(12) United States Patent (10) Patent No.: US 9,677,055 B2 Jones Et Al
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Tissue-Resident Γδt Cells As Gatekeepers of Psoriatic Skin Inflammation and Dietary Interventions
Wo 2010/095940 A2
Assessment of the Evolution of Cancer Treatment Therapies
Scanning for Therapeutic Targets Within the Cytokine Network of Idiopathic Inflammatory Myopathies
Customs Tariff - Schedule Xxi - 1
T Lymphocytes in the Intestinal Mucosa: Defense and Tolerance
Cytokine-Mediated Crosstalk Between Immune Cells and Epithelial Cells in the Gut
Biologics in Inflammatory Bowel Disease
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Download Curriculum Vitae
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
(INN) for Biological and Biotechnological Substances
Download Curriculum Vitae
Thalidomide - Wikipedia, the Free Encyclopedia
Surface Layer Proteins As Virulence Factors in Clostridium Difficile Infection
(12) United States Patent (10) Patent No.: US 7,365,168 B2 Hinton Et Al
Therapeutic Targets for Emerging Biologic Therapies in IBD 4
Part III the Delicate Balance of the Immune System Between Tolerance
International Nonproprietary Names (INN) for Biological and Biotechnological Substances